-

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of 3D Systems Corporation (DDD) Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired 3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD) securities between May 6, 2020 and March 1, 2021, inclusive (the “Class Period”). 3D Systems investors have until June 8, 2021 to file a lead plaintiff motion.

If you suffered a loss on your 3D Systems investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/3d-systems-corporation/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

3D Systems is a holding company that offers three-dimensional (3D) printing solutions, including 3D printers, print materials, software, on demand manufacturing services and digital design tools.

On March 1, 2021, 3D Systems issued a press release advising investors that it will delay the filing of its annual report on a Form 10-K. The Company stated that “the delay in filing is primarily related to the presentation of cash flows associated with the divestiture process for its Cimatron and GibbsCam software businesses.” 3D Systems also stated that it had identified “certain internal control deficiencies” and that, as a result, it would “report material weaknesses in internal controls in its fiscal 2020 Annual Report on Form 10-K.”

On March 2, 2021, 3D Systems filed a NT-10K with the SEC, stating that its 10-K filing would be delayed for the reasons listed in their March 1, 2021 press release.

On this news, 3D Systems’ stock price fell $7.62 per share, or 19.6%, to close at $31.17 per share on March 2, 2021, thereby injuring investors.

The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) 3D Systems lacked proper internal controls over financial reporting; and (2) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired 3D Systems securities during the Class Period, you may move the Court no later than June 8, 2021 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com
shareholders@glancylaw.com

Glancy Prongay & Murray LLP

NYSE:DDD

Release Versions
$Cashtags

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com
shareholders@glancylaw.com

More News From Glancy Prongay & Murray LLP

Lost Money on Madrigal Pharmaceuticals, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 8.1% Share Price Drop

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) investors into whether the Company may have violated the federal securities laws. The investigation follows the November 3, 2026 disclosure regarding Madrigal Pharmaceuticals,...

Lost Money on Dave, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 21.25% Share Price Drop

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Dave, Inc. ("Dave" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Dave, Inc. (NASDAQ: DAVE) investors into whether the Company may have violated the federal securities laws. The investigation follows the November 4, 2026 disclosure regarding Dave, Inc. Investors who lost money on Dave, Inc. securities can submi...

Lost Money on MNTN, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 53.62% Share Price Drop

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on MNTN, Inc. ("MNTN" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of MNTN, Inc. (NYSE: MNTN) investors into whether the Company may have violated the federal securities laws. The investigation follows the November 4, 2026 disclosure regarding MNTN, Inc.Investors who lost money on MNTN, Inc. securities can submit th...
Back to Newsroom